CERO THERAPEUTICS HOLDINGS, INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q2 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Cero Therapeutics Holdings, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2021 to Q1 2023.
  • Cero Therapeutics Holdings, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$198K, a 35.8% increase year-over-year.
  • Cero Therapeutics Holdings, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$1.52M, a 39.5% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 -$198K +$110K +35.8% Mar 31, 2023 10-Q 2023-05-12
Q1 2022 -$308K Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $0 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 Jun 30, 2021 10-Q 2022-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.